These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37054762)

  • 1. Benefits of early rhythm control of atrial fibrillation.
    Eckardt L; Wolfes J; Frommeyer G
    Trends Cardiovasc Med; 2024 Jul; 34(5):288-294. PubMed ID: 37054762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate versus rhythm control for atrial fibrillation: from AFFIRM to EAST-AFNET 4 - a paradigm shift.
    Roman S; Patel K; Hana D; Guice KC; Patel J; Stadnick C; Basta A; Khouzam RN
    Future Cardiol; 2022 Apr; 18(4):354-353. PubMed ID: 35255732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation.
    Dickow J; Kirchhof P; Van Houten HK; Sangaralingham LR; Dinshaw LHW; Friedman PA; Packer DL; Noseworthy PA; Yao X
    J Am Heart Assoc; 2022 Jun; 11(11):e024214. PubMed ID: 35621202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Willems S; Borof K; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Gessler N; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Ng GA; Schnabel RB; Suling A; Szumowski L; Themistoclakis S; Vardas P; van Gelder IC; Wegscheider K; Kirchhof P
    Eur Heart J; 2022 Mar; 43(12):1219-1230. PubMed ID: 34447995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA Trial.
    Bunch TJ; Poole JE; Silverstein AP; Lee KL; Al-Khalidi HR; Hindricks G; Romanov A; Pokushalov E; Bahnson TD; Daniels MR; Piccini JP; Mark DB; Packer DL;
    Circ Arrhythm Electrophysiol; 2024 May; 17(5):e012697. PubMed ID: 38629286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
    Camm AJ; Naccarelli GV; Mittal S; Crijns HJGM; Hohnloser SH; Ma CS; Natale A; Turakhia MP; Kirchhof P
    J Am Coll Cardiol; 2022 May; 79(19):1932-1948. PubMed ID: 35550691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation: the rate versus rhythm management controversy.
    Camm AJ; Savelieva I
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():23-34. PubMed ID: 22518391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
    Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
    BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST.
    Arbelo E; Dagres N
    Europace; 2022 Jun; 24(Suppl 2):ii3-ii7. PubMed ID: 35661865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.
    Metzner A; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Haegeli LM; Heidbuchel H; Kautzner J; Kuck KH; Mont L; Ng GA; Szumowski L; Themistoclakis S; van Gelder IC; Vardas P; Wegscheider K; Willems S; Kirchhof P
    Europace; 2022 Apr; 24(4):552-564. PubMed ID: 34473249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation.
    Viles-Gonzalez JF; Fuster V; Halperin J; Calkins H; Reddy VY
    Clin Cardiol; 2011 Jan; 34(1):23-9. PubMed ID: 21259274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.
    Andrade JG; Wells GA; Deyell MW; Bennett M; Essebag V; Champagne J; Roux JF; Yung D; Skanes A; Khaykin Y; Morillo C; Jolly U; Novak P; Lockwood E; Amit G; Angaran P; Sapp J; Wardell S; Lauck S; Macle L; Verma A;
    N Engl J Med; 2021 Jan; 384(4):305-315. PubMed ID: 33197159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH; Warraich M; Whitfield MG; Peter CU; Baral R; Ahmad M; Ahmad S; Abraham GR; Kirresh A; Sahibzada MS; Muzaffar A; Tomson J; Lambiase PD; Captur G; Banerjee A; Providencia R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013765. PubMed ID: 36915032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
    N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Kany S; Cardoso VR; Bravo L; Williams JA; Schnabel R; Fabritz L; Gkoutos GV; Kirchhof P
    Heart; 2022 Nov; 108(23):1873-1880. PubMed ID: 35835543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate control versus rhythm control in atrial fibrillation: lessons learned from clinical trials of atrial fibrillation.
    Waldo AL
    Prog Cardiovasc Dis; 2015; 58(2):168-76. PubMed ID: 26260611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.